CEA-targeted CAR-T (Intravenous)
2025-0883
Phase 1 mab active
Quick answer
CEA-targeted CAR-T (Intravenous) for NSCLC (Advanced Non-small Cell Lung Cancer) is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- NSCLC (Advanced Non-small Cell Lung Cancer)
- Phase
- Phase 1
- Modality
- mab
- Status
- active